Low-Dose Aspirin Protects the Neurovascular Unit through Lysine Acetylation of Histone in an Oxygen–Glucose Deprivation Model of Cerebral Ischemia
Low-dose aspirin is widely used as a low-cost prophylactic against atherosclerotic cardiovascular disease and for secondary prevention of ischemic stroke due to its anti-platelet action that is mediated by serine acetylation of cyclooxygenase (COX) enzymes. However, whether beneficial effects of low-dose aspirin are mediated by direct protective effect on the cells of the neurovascular unit that is platelet-independent, remain unclear. Here, we investigated the effects of chronic low-concentration (10 µM) aspirin pretreatment in cultured brain vascular endothelial cells and neurons subjected to sub-lethal in vitro cerebral ischemia via 4 hoxygen-glucose deprivation (OGD). Chronic aspirin pretreatment abolished the OGD-induced increase in Mcp1/Ccl2 transcript expression suggesting attenuation of inflammatory signalling. This was accompanied by anincreased lysine acetylation on a protein having same molecular weight as histone 3 (H3). Molecular docking calculations showed that aspirin can indeed bind to the lysine residues of H3, with the acetyl group of aspirin being in close contact with side chain lysine residues. Together, these observations indicate low-dose prophylactic aspirin can produce brain cell type-specific anti-inflammatory effect in response to ischemic stress that is associated with lysine acetylation of histone protein.
Authors
- Rajas Rao (ORCID: https://orcid.org/0000-0003-4766-2645)
- Manju Babu (ORCID: https://orcid.org/0000-0001-5389-5213)
- Anaekshi Gogoi (ORCID: https://orcid.org/0009-0004-8826-8825)
- Abhina Gangadhar (ORCID: https://orcid.org/0009-0002-8244-5769)
- Riyama Shirin (ORCID: https://orcid.org/0009-0004-3676-9337)
- Arnab Datta
- Deepthi Ann Thomas
Institutions
- Yenepoya University (IN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-11548410/v1
- Primary Topic
- Neuroprotection in Cerebral Ischemia
- Type
- preprint